12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Progenics preclinical data

In hamsters infected with C. difficile, 19 of 20 animals treated with a combination of mAbs targeting C. difficile antitoxin A and antitoxin B survived to...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >